| Mepha Pharma AG - Oxycodon-Naloxon-Mepha 5 mg/2.5 mg, Retardtabletten | | 65742 | | 01 | | Oxycodon-Naloxon-Mepha 5 mg/2.5 mg | | Retardtabletten | | N02AA55 | | Oxycodone and Naloxone | | 26.08.2016 | | |
| | Composition | | oxycodoni hydrochloridum 5 mg, naloxoni hydrochloridum anhydricum 2.5 mg ut naloxoni hydrochloridum dihydricum, povidonum K 30, poly(vinylis acetas), natrii laurilsulfas corresp. natrium 0.02 mg, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, E 171, macrogolum 3350, pro compresso obducto. | | Packungsbestandteile | | Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Naloxone Hydrochloride Anhydrate | 2.5 mg | | Oxycodone Hydrochloride | 5 mg |
| | BAG: Active Agent | Dose |
|---|
| Naloxone Hydrochloride Anhydrate | 2.5 mg | | Oxycodone Hydrochloride | 5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Cellulosum Microcristallinum | | | | E 171 | | color. | | Macrogol | 3350 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Poly(Vinylis Acetas) | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| |
|
